Fig. 6From: TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinomaAssociation of TET1 mutations with drug responses and drug selection of COAD cells. Correlations between TET1 mutations (A), missense mutations (B), and drug responses (C). Violin plots of drug selection of COAD cellsBack to article page